Mitochondrial‐DNA‐Targeted IrIII‐Containing Metallohelices with Tunable Photodynamic Therapy Efficacy in Cancer Cells

The development of DNA‐targeted photodynamic therapy (PDT) agents for cancer treatment has drawn substantial attention. Herein, the design and synthesis of dinuclear Ir^III‐containing luminescent metallohelices with tunable PDT efficacy that target mitochondrial DNA in cancer cells are reported. The metallohelices are fabricated using dynamic imine‐coupling chemistry between aldehyde end‐capped fac‐Ir(ppy)₃ handles and linear alkanediamine spacers, followed by reduction of the imine linkages. The length and odd–even character of the diamine alkyl linker determined the stereochemistry (helicates vs. mesocates). Compared to the helicates, the mesocates exhibit improved apoptosis‐induction upon white‐light irradiation. Molecular docking studies indicate that the mesocate with a proper length of diamine spacers shows stronger affinity for the minor groove of DNA. This study highlights the potential of DNA‐targeting Ir^III‐containing metallohelices as PDT agents.     

meso‐(2‐Pyridyl)‐boron(III)‐subporphyrin: Perimeter Iridium(III) Coordination

Peripherally metalated porphyrinoids are promising functional π‐systems displaying characteristic optical, electronic, and catalytic properties. In this work, 5‐(2‐pyridyl)‐ and 5,10,15‐tri(2‐pyridyl)‐B^III‐subporphyrins were prepared and used to produce cyclometalated subporphyrins by reactions with [Cp*IrCl₂]₂, which proceeded through an efficient C?H activation to give the corresponding mono‐ and tri‐Ir^III complexes, respectively. While the mono‐Ir^III complex was obtained as a diastereomeric mixture, a C₃‐symmetric tri‐Ir^III complex with the three Cp*‐units all at the concave side was predominantly obtained in a high yield of 90 %, which displays weak NIR phosphorescence even at room temperature in degassed CH₂Cl₂, differently from the mono‐Ir^III complexes.     

Tuning the Cellular Uptake Properties of Luminescent Heterobimetallic Iridium(III)–Ruthenium(II) DNA Imaging Probes

The synthesis of two new luminescent dinuclear Ir^III–Ru^II complexes containing tetrapyrido[3,2‐a:2′,3′‐c:3′′,2′′‐h:2′′′,3′′′‐j]phenazine (tpphz) as the bridging ligand is reported. Unlike many other complexes incorporating cyclometalated Ir^III moieties, these complexes display good water solubility, allowing the first cell‐based study on Ir^III–Ru^II bioprobes to be carried out. Photophysical studies indicate that emission from each complex is from a Ru^II excited state and both complexes display significant in vitro DNA‐binding affinities. Cellular studies show that each complex is rapidly internalised by HeLa cells, in which they function as luminescent nuclear DNA‐imaging agents for confocal microscopy. Furthermore, the uptake and nuclear targeting properties of the complex incorporating cyclometalating 2‐(4‐fluorophenyl)pyridine ligands around its Ir^III centre is enhanced in comparison to the non‐fluorinated analogue, indicating that fluorination may provide a route to promote cell uptake of transition‐metal bioprobes.     

A Cyclometalated IrIII Complex Conjugated to a Coumarin Derivative Is a Potent Photodynamic Agent against Prostate Differentiated and Tumorigenic Cancer Stem Cells

A cyclometalated Ir^III complex conjugated to a far-red-emitting coumarin, Ir^III-COUPY ( 3 ), was recently shown as a very promising photosensitizer suitable for photodynamic therapy of cancer. Therefore, the primary goal of this work was to deepen knowledge on the mechanism of its photoactivated antitumor action so that this information could be used to propose a new class of compounds as drug candidates for curing very hardly treatable human tumors, such as androgen resistant prostatic tumors of metastatic origin. Conventional anticancer chemotherapies exhibit several disadvantages, such as limited efficiency to target cancer stem cells (CSCs), which are considered the main reason for chemotherapy resistance, relapse, and metastasis. Herein, we show, using DU145 tumor cells, taken as the model of hormone-refractory and aggressive prostate cancer cells resistant to conventional antineoplastic drugs, that the photoactivated conjugate 3 very efficiently eliminates both prostate bulk (differentiated) and prostate hardly treatable CSCs simultaneously and with a similar efficiency. Notably, the very low toxicity of Ir^III-COUPY conjugate in the prostate DU145 cells in the dark and its pronounced selectivity for tumor cells compared with noncancerous cells could result in low side effects and reduced damage of healthy cells during the photoactivated therapy by this agent. Moreover, the experiments performed with the 3D spheroids formed from DU145 CSCs showed that conjugate 3 can penetrate the inner layers of tumor spheres, which might markedly increase its therapeutic effect. Also interestingly, this conjugate induces apoptotic cell death in prostate cancer DU145 cells associated with calcium signaling flux in these cells and autophagy. To the best of our knowledge, this is the first study demonstrating that a photoactivatable metal-based compound is an efficient agent capable of killing even hardly treatable CSCs.     

Cyclometalated Mono‐ and Dinuclear IrIII Complexes with “Click”‐Derived Triazoles and Mesoionic Carbenes

Orthometalation at Ir^III centers is usually facile, and such orthometalated complexes often display intriguing electronic and catalytic properties. By using a central phenyl ring as C?H activation sites, we present here mono‐ and dinuclear Ir^III complexes with “click”‐derived 1,2,3‐triazole and 1,2,3‐triazol‐5‐ylidene ligands, in which the wingtip phenyl groups in the aforementioned ligands are additionally orthometalated and bind as carbanionic donors to the Ir^III centers. Structural characterization of the complexes reveal a piano stool‐type of coordination around the metal centers with the “click”‐derived ligands bound either with C^N or C^C donor sets to the Ir^III centers. Furthermore, whereas bond localization is observed within the 1,2,3‐triazole ligands, a more delocalized situation is found in their 1,2,3‐triazol‐5‐ylidene counterparts. All complexes were subjected to catalytic tests for the transfer hydrogenation of benzaldehyde and acetophenone. The dinuclear complexes turned out to be more active than their mononuclear counterparts. We present here the first examples of stable, isomer‐pure, dinuclear cyclometalated Ir^III complexes with poly‐mesoionic‐carbene ligands.     

Mitochondrial-DNA-Targeted IrIII-Containing Metallohelices with Tunable Photodynamic Therapy Efficacy in Cancer Cells

The development of DNA-targeted photodynamic therapy (PDT) agents for cancer treatment has drawn substantial attention. Herein, the design and synthesis of dinuclear Ir^III-containing luminescent metallohelices with tunable PDT efficacy that target mitochondrial DNA in cancer cells are reported. The metallohelices are fabricated using dynamic imine-coupling chemistry between aldehyde end-capped fac-Ir(ppy)₃ handles and linear alkanediamine spacers, followed by reduction of the imine linkages. The length and odd–even character of the diamine alkyl linker determined the stereochemistry (helicates vs. mesocates). Compared to the helicates, the mesocates exhibit improved apoptosis-induction upon white-light irradiation. Molecular docking studies indicate that the mesocate with a proper length of diamine spacers shows stronger affinity for the minor groove of DNA. This study highlights the potential of DNA-targeting Ir^III-containing metallohelices as PDT agents.     

The correct assignment of stereochemistry in di‐μ‐dichlorido‐bis{bis[2‐(5‐benzylsulfonyl)‐3‐fluoro‐2‐(pyridin‐2‐yl)phenyl‐κ2N,C1]iridium(III)} toluene monosolvate

The title complex, [Ir₂(C₁₈H₁₃FNO₂S)₄Cl₂]·C₇H₈, was crystallized from dichloromethane solution under a toluene atmosphere. It is a dimeric complex in which each of the two Ir^III centres is octahedrally coordinated by two bridging chloride ligands and by two chelating cyclometalated 2‐(4‐benzylsulfonyl‐2‐fluorophenyl)pyridine ligands. The crystal structure analysis unequivocally establishes the trans disposition of the two cyclometalated ligands bound to each Ir^III centre, contrary to our previous hypothesis of a cis disposition. The latter was based on the ¹H NMR spectra of a series of dimeric benzylsulfonyl‐functionalized dichloride‐bridged iridium complexes, including the compound described in the present work [Ragni et al. (2009). Chem. Eur. J. 15 , 136–148]. The toluene solvent molecules, embedded in cavities in the crystal structure, are highly disordered and could not be modelled successfully; their contribution was removed from the refinement using the SQUEEZE routine in the program PLATON [Spek (2009). Acta Cryst. D 65 , 148–155].     

Encapsulation and Enhanced Luminescence Properties of IrIII Complexes within a Hexameric Self‐Assembled Capsule

Encapsulation and luminescence studies of [Ir(ppy)₂(bpy)]Cl (ppy=2‐phenylpyridinate, bpy=2,2′‐bipyridine) within a hexameric resorcinarene capsule are reported. One Ir^III complex cation was encapsulated within the capsule, as demonstrated by NMR and dynamic light scattering (DLS) studies. The emission color of the Ir^III complex was drastically changed from orange to yellow by encapsulation, in contrast with the lack of significant changes in the absorption spectrum. The hexameric capsule effectively hampers the non‐radiative pathway to increase both the luminescence quantum yield and the exited state lifetime. The luminescent properties of the encapsulated Ir^III complex depend on the ratio of Ir^III complex to the resorcinarene monomer as well as the concentration of resorcinarene monomer owing to the reversible process of self‐assembly of the hexameric capsule. Quenching experiments revealed that the Ir^III complex in the capsule was effectively separated from quenchers.     

Sensitized near-infrared emission of Yb from an Ir–Yb bimetallic complex

A new cyclometalated ligand 1,3-dimethyl-5-phenyl-1H-[1,2,4]-triazole (pdt) was designed and synthesized. And the corresponding Ir^III complex Ir(pdt)₂(phen5f) (phen5f stands for 4,4,5,5,5-pentafluoro-1-(1′,10′-phenanthrolin-2′-yl)-pentane-1,3-dionate) was obtained. According to the measurement of the lowest triplet state energy level of Ir(pdt)₂(phen5f), it is suitable for sensitizing NIR (near-infrared) lanthanide ions instead of Eu^III. The bimetallic complex [(pdt)₂Ir(μ-phen5f)YbCl₂ · 2CH₃CH₂OH · H₂O]Cl was synthesized by the approach of “complexes as ligands”. Data showed that the emission quenching was observed in the solid state when the Ir^III–Yb^III complex was compared with the Ir^III complex, which implied that energy transfer might occur from Ir^III complex-ligand to Yb^III ion. Upon irradiation of the MLCT (metal-to-ligand charge transfer) absorption of Ir(pdt)₂(phen5f), the characteristic emission of Yb^III was obtained with the peak around 978 nm.     

Novel Phosphorescent Hydrogels Based on an IrIII Metal Complex

Novel phosphorescent hydrogels have been explored by immobilizing an Ir^III metal complex into the matrices of hydrogels. FTIR spectra demonstrate that the Ir^III–PNaAMPS hydrogel is achieved by irreversible incorporation of positively charged [Ir(ppy)₂(dmbpy)]Cl (ppy = 2‐phenylpyrine, dmbpy = 4,4′‐dimethyl‐2,2′‐bipyridine) into negatively charged poly(2‐acrylamido‐2‐methylpropane sulfonic acid sodium) (PNaAMPS) hydrogel via electrostatic interaction. The photoluminescent spectra indicate that the Ir^III–PNaAMPS hydrogel exhibits stable phosphorescence. In vitro cultivation of human retinal pigment epithelial cells demonstrates the cytocompatibility of the Ir^III–PNaAMPS hydrogel. This work herein represents a facile pathway for fabrication of phosphorescent hydrogels.     

Syntheses,Photophysics, and Application of Iridium(III) Phosphorescent Emitters for Highly Efficient,Long‐Life Organic Light‐Emitting Diodes

Long live the OLED! Rational design and synthesis of Ir^III complexes bearing two cyclometalated ligands (C N) and one 2‐(diphenylphosphino)phenolate chelate (P O) as well as the corresponding Ir^III derivatives with only one (C N) ligand and two P O chelates are reported. According to the observed photophysical data, a P O ligand is found to be able to fine‐tune the light‐emitting electronic transition of these complexes.

     

Tuning the Excited State of Water‐Soluble IrIII‐Based DNA Intercalators that are Isostructural with [RuII(NN)2(dppz)] Light‐Switch Complexes

The synthesis of two new Ir^III complexes which are effectively isostructural with well‐established [Ru(NN)₂(dppz)]²⁺ systems is reported (dppz=dipyridophenazine; NN=2,2′‐bipyridyl, or 1,10‐phenanthroline). One of these Ir^III complexes is tricationic and has a conventional N₆ coordination sphere. The second dicationic complex has a N₅C coordination sphere, incorporating a cyclometalated analogue of the dppz ligand. Both complexes show good water solubility. Experimental and computational studies show that the photoexcited states of the two complexes are very different from each other and also differ from their Ru^II analogues. Both of the complexes bind to duplex DNA with affinities that are two orders of magnitude higher than previously reported Ir(dppz)‐based systems and are comparable with Ru^II(dppz) analogues.     

Energy Transfer in a Hybrid IrIII Carbene–PtII Acetylide Assembly for Efficient Hydrogen Production

A new heterometallic supramolecular complex, consisting of an iridium carbene‐based unit appended to a platinum terpyridine acetylide unit, representing a new Ir^III–Pt^II structural motif, was designed and developed to act as an active species for photocatalytic hydrogen production. The results also suggested that a light‐harvesting process is essential to realize the solar‐to‐fuel conversion in an artificial system as illustrated in the natural photosynthetic system.     

Phosphorescent Trinuclear Pt–Ir–Pt Complexes: Insights into the Photophysical and Electrochemical Properties and Interaction with Guanine Nucleobase

In this study we have analysed the comparative photophysical and electrochemical properties of two isomeric heterotrinuclear Pt^II–Ir^III–Pt^II complexes 3 and 6 and the four corresponding intermediate isomeric homonuclear cyclometalated iridium(III) complexes 1 , 2 , 4 and 5 . The isomerisation originates from positional differences in the formyl, di-2-picolylamine and Pt–di-2-picolylamine moieties appended to cyclometalated or ancillary ligands. The interaction of 5′-GMP with the trinuclear complexes 3 and 6 shows that platinum centres appended to the cyclometalated ligand in 3 facilitate the binding of two 5′-GMP units per Pt^II centre in preference to a single 5′-GMP unit per Pt^II centre as observed in 6 . The 1:2 and 1:1 Pt^II–5′-GMP binding patterns probably arise from the convenient arrangements of the Pt–di-2-picolylamine units in different planes in complex 3 , which is absent in complex 6 .     

2‐(2′‐Pyridyl)‐4,6‐diphenylphosphinine versus 2‐(2′‐Pyridyl)‐4,6‐diphenylpyridine: Synthesis,Characterization, and Reactivity of Cationic RhIII and IrIII Complexes Based on Aromatic Phosphorus Heterocycles

The bidentate P,N hybrid ligand 1 allows access for the first time to novel cationic phosphinine‐based Rh^III and Ir^III complexes, broadening significantly the scope of low‐coordinate aromatic phosphorus heterocycles for potential applications. The coordination chemistry of 1 towards Rh^III and Ir^III was investigated and compared with the analogous 2,2′‐bipyridine derivative, 2‐(2′‐pyridyl)‐4,6‐diphenylpyridine ( 2 ), which showed significant differences. The molecular structures of [RhCl(Cp*)( 1 )]Cl and [IrCl(Cp*)( 1 )]Cl (Cp*=pentamethylcyclopentadienyl) were determined by means of X‐ray diffraction and confirm the mononuclear nature of the λ³‐phosphinine–Rh^III and Ir^III complexes. In contrast, a different reactivity and coordination behavior was found for the nitrogen analogue 2 , especially towards Rh^III as a bimetallic ion pair [RhCl(Cp*)( 2 )]⁺[RhCl₃(Cp*)]^? is formed rather than a mononuclear coordination compound. [RhCl(Cp*)( 1 )]Cl and [IrCl(Cp*)( 1 )]Cl react with water regio‐ and diastereoselectively at the external P?C double bond, leading exclusively to the anti‐addition products [MCl(Cp*)( 1 H ? OH)]Cl as confirmed by X‐ray crystal‐structure determination.     

Visible Light Induced Rhodium(I)‐Catalyzed C−H Borylation

An efficient visible light induced rhodium(I)‐catalyzed regioselective borylation of aromatic C?H bonds is reported. The photocatalytic system is based on a single NHC?Rh^I complex capable of both harvesting visible light and enabling the bond breaking/forming at room temperature. The chelating nature of the NHC‐carboxylate ligand was critical to ensure the stability of the Rh^I complex and to provide excellent photocatalytic activities. Experimental mechanistic studies evidenced a photooxidative ortho C?H bond addition upon irradiation with blue LEDs, leading to a cyclometalated Rh^III‐hydride intermediate.     

Room‐Temperature Decarboxylative Couplings of α‐Oxocarboxylates with Aryl Halides by Merging Photoredox with Palladium Catalysis

Enabled by merging iridium photoredox catalysis and palladium catalysis, α‐oxocarboxylate salts can be decarboxylatively coupled with aryl halides to generate aromatic ketones and amides at room temperature. DFT calculations suggest that this reaction proceeds through a Pd⁰–Pd^II–Pd^III pathway, in which the Pd^III intermediate is responsible for reoxidizing Ir^II to complete the Ir^III–*Ir^III–Ir^II photoredox cycle.     

Dipyrrinato-Iridium(III) Complexes for Application in Photodynamic Therapy and Antimicrobial Photodynamic Inactivation

The generation of bio-targetable photosensitizers is of utmost importance to the emerging field of photodynamic therapy and antimicrobial (photo-)therapy. A synthetic strategy is presented in which chelating dipyrrin moieties are used to enhance the known photoactivity of iridium(III) metal complexes. Formed complexes can thus be functionalized in a facile manner with a range of targeting groups at their chemically active reaction sites. Dipyrrins with N- and O-substituents afforded (dipy)iridium(III) complexes via complexation with the respective Cp*-iridium(III) and ppy-iridium(III) precursors (dipy=dipyrrinato, Cp*=pentamethyl-η⁵-cyclopentadienyl, ppy=2-phenylpyridyl). Similarly, electron-deficient [Ir^III(dipy)(ppy)₂] complexes could be used for post-functionalization, forming alkenyl, alkynyl and glyco-appended iridium(III) complexes. The phototoxic activity of these complexes has been assessed in cellular and bacterial assays with and without light; the [Ir^III(Cl)(Cp*)(dipy)] complexes and the glyco-substituted iridium(III) complexes showing particular promise as photomedicine candidates. Representative crystal structures of the complexes are also presented.     

DFT Methods to Study the Reaction Mechanism of Iridium‐Catalyzed Hydrogenation of Olefins: Which Functional Should be Chosen?

To enable the selection of more accurate computational methods for the future theoretical exploration of the reaction mechanism of Ir‐catalyzed olefin hydrogenation, we compared high‐level ab initio coupled cluster and DFT calculations with a simplified model of Pfaltz's Ir/P,N‐type catalyst for all four previously proposed Ir^I/Ir^III and Ir^III/Ir^V mechanisms. Through the systematic assessment of the DFT performances, the DFT empirical dispersion correction (DFT‐D3) is found to be indispensable for improving the accuracy of relative energies between the Ir^I/Ir^III and Ir^III/Ir^V mechanisms. After including the DFT‐D3 correction, the three best performing density functionals (DFs) are B2‐PLYP, BP86, and TPSSh. In these recommended DFs, the computationally more expensive double‐hybrid functional B2‐PLYP‐D3 has a balanced and outstanding performance for calculations of the reaction barriers, reaction energies, and energy gaps between different mechanisms, whereas the less costly BP86‐D3 and TPSSh‐D3 methods have outstanding, but relatively less uniform performances.     

Tris‐cyclometalated Iridium(III) Complexes with Three Different Ligands: a New Example with 2‐(2,4‐Difluorophenyl)pyridine‐Based Complex

An iridium(III) complex comprising three different cyclometalated phenylpyridine‐based ligands was designed and synthesized. Interestingly, mixed‐ligand complexes could be obtained by using a simple and straightforward procedure. A tris(heteroleptic) Ir^III complex was obtained as a mixture of stereoisomers that could not be separated. Photophysical properties of the tris(heteroleptic) complex was investigated by UV/VIS absorption and luminescence spectroscopy, and compared with those of the parent homoleptic complexes. Modelling by time‐dependent density functional theory (TD‐DFT) was also performed to elucidate the nature and the location of the excited state, and to support the experimental results.